AIP
NXTC icon

Ameritas Investment Partners’s NextCure NXTC Stock Holding History

Ameritas Investment Partners’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-101
Closed -$12K – 3178
2021
Q1 		$12K Hold
101
– – ﹤0.01% 2779
2020
Q4 		$13K Hold
101
– – ﹤0.01% 2685
2020
Q3 		$11K Hold
101
– – ﹤0.01% 2669
2020
Q2 		$26K Hold
101
– – ﹤0.01% 2210
2020
Q1 		$45K Hold
101
– – ﹤0.01% 1726
2019
Q4 		$68K Buy
101
+80
+381% +$40.1K ﹤0.01% 1733
2019
Q3 		$8K Hold
21
– – ﹤0.01% 2816
2019
Q2 		$4K Buy
+21
New +$4.37K ﹤0.01% 2969

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's NXTC Position: Q2 2021 in Review

Ameritas Investment Partners sold out of NextCure (NXTC) in Q2 2021, closing a stake of 101 shares — an estimated $12K sold.

Ameritas Investment Partners first reported a position in NXTC in Q2 2019 and held it in 8 quarters. The position peaked at $68K in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • Ameritas Investment Partners reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 101 NextCure shares in Q2 2021, an estimated $12K.
  • Ameritas Investment Partners first reported a position in NextCure in Q2 2019 and held it in 8 quarters.
  • Ameritas Investment Partners's NextCure position peaked at $68K in Q4 2019.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.